Healthcare
Henry Schein, Inc.(HSIC)
Live Price
Offline$79.92
-0.06% today
1Y Change
+9.25%
Window
Jun 26, 2025 โ Jun 18, 2026
- Market Cap
- $8.56B
- Revenue Growth
- +4.0%
- EPS Growth
- +7.2%
- Dividend Yield
- 0.0%
Coverage: 246 bars ยท Jun 26, 2025 โ Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Henry Schein, Inc. (HSIC) is a Healthcare stock with a market cap of $8.56B and listed on NASDAQ. The stock last traded around $79.92 and up 9.3% across the available one-year price window (Jun 26, 2025 โ Jun 18, 2026). Baseline metrics include revenue growth of +4.0%, EPS growth of +7.2%, a dividend yield of 0.0%. What stands out right now is revenue +4.0%, EPS +7.2%, free cash flow -13.3% with operating margin 5.8% and ROIC 6.7%. Valuation is more restrained than many high-expectation growth names at P/E 22.0 and price/sales 0.6. Stock Foundry combines HSIC price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+4.0% vs +7.6% peer median
Operating Margin
Below sector median
+5.8% vs +19.4% peer median
P/E
Below sector median
22.0 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 4, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +4.0% and EPS at +7.2%, with operating margin around 5.8%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -1.9% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 4, 2026 | โ | +3.3% | -4.2% | +5.6% |
2026 Feb 24, 2026 | +3.1% | -1.7% | -3.8% | -11.2% |
2025 Nov 4, 2025 | +8.7% | +0.6% | +2.2% | +1.8% |
Benchmark Edge
HSIC vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HSIC
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HSIC Max Drawdown
-17.23%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for HSIC and SPY.
Company Overview
Henry Schein, Inc.
NASDAQ Global Select
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
- Leadership
- Andrea Albertini
- IPO Date
- Nov 3, 1995
- Employees
- 25.0k
- Street Address
- 135 Duryea Road
- Mailing
- Melville, NY, 11747
- Region
- Melville, NY, US
- Reporting Currency
- USD
- Investor Line
- 631 843 5500
- Last Updated
- Apr 30, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 22.0
- EV/EBITDA
- 12.1
- Price/Sales
- 0.6
- Price/Book
- 2.7
Growth
- Revenue
- +4.0%
- EPS
- +7.2%
- Free Cash Flow
- -13.3%
Profitability
- Gross Margin
- 29.1%
- Operating Margin
- 5.8%
- Net Margin
- 3.0%
- ROE
- 11.9%
- ROIC
- 6.7%
Balance Sheet
- Debt/Equity
- 1.14
- Current Ratio
- 1.38
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.